|Tubal ligation / BTL surgery|
Tubal ligation surgery
|Failure rates (first year)|
|Advantages and disadvantages|
|Risks||Operative and postoperative complications|
Tubal ligation (commonly known as having one's "tubes tied") is a surgical procedure for female sterilization in which the fallopian tubes are permanently blocked or removed. This prevents the fertilization of eggs by sperm and thus the implantation of a fertilized egg. Tubal ligation is considered a permanent method of sterilization and birth control.
Female sterilization through tubal ligation is primarily used to permanently prevent a patient from having a spontaneous pregnancy (as opposed to pregnancy via in vitro fertilization) in the future. While both hysterectomy (the removal of the uterus) or bilateral oophorectomy (the removal of both ovaries) can also accomplish this goal, these surgeries carry generally greater health risks than tubal ligation procedures.
Less commonly, tubal ligation procedures may also be performed for patients who are known to be carriers of genes that increase the risk of ovarian and fallopian tube cancer, such as BRCA1 and BRCA2. While the procedure for these patients still results in sterilization, the procedure is chosen preferentially among these patients who have completed childbearing, with or without a simultaneous oophorectomy.
Benefits and advantages for use as contraception
Most methods of female sterilization are approximately 99% effective or greater in preventing pregnancy. These rates are roughly equivalent to the effectiveness of long-acting reversible contraceptives such as intrauterine devices and contraceptive implants, and slightly less effective than permanent male sterilization through vasectomy. These rates are significantly higher than other forms of modern contraception that require regular active engagement by the user, such as oral contraceptive pills or male condoms.
(See also: Comparison of birth control methods)
Avoidance of hormonal medications
Many forms of female-controlled contraception rely on suppression of the menstrual cycle using progesterones and/or estrogens. For patients who wish to avoid hormonal medications because of personal medical contraindications such as breast cancer, unacceptable side effects, or personal preference, tubal ligation offers highly effective birth control without the use of hormones.
Reduction of pelvic inflammatory disease risk
Occluding or removing both fallopian tubes decreases the likelihood that a sexually transmitted infection can ascend from the vagina to the abdominal cavity, causing pelvic inflammatory disease (PID) or a tubo-ovarian abscess. Tubal ligation does not completely eliminate the risk of PID, and does not offer protection against sexually transmitted infections.
Reduction of ovarian and fallopian tube cancer risk
Partial tubal ligation or full salpingectomy (a tubal ligation method that relies upon the physical removal of the fallopian tube) reduces the lifetime risk of developing ovarian or fallopian tube cancer later in life. This is true both for patients who are already known to be at high risk for ovarian or fallopian tube cancer secondary to genetic mutations, as well as women who have the baseline population risk.
Risks and complications
Risks associated with surgery and anesthesia
Most tubal ligation procedures involve accessing the abdominal cavity through incisions in the abdominal wall and require some form of regional or general anesthesia (see Procedure technique below). Major complications from laparoscopic surgery may include need for blood transfusion, infection, conversion to open surgery, or unplanned additional major surgery, while complications from anesthesia itself may include hypoventilation and cardiac arrest. Major complications during female sterilization are uncommon, occurring in an estimated 0.1-3.5% of laparoscopic procedures, with mortality rates in the United States estimated at 1-2 patient deaths per 100,000 procedures. These complications are more common for patients with a history of previous abdominal or pelvic surgery, obesity, and/or diabetes.
While female sterilization procedures are highly effective at preventing pregnancy, there is a small continuing risk of unintended pregnancy after tubal ligation. Several factors influence the likelihood of failure: increased time since sterilization, younger age at the time of sterilization, and certain methods of sterilization are all associated with increased risk of failure. Pregnancy rates at 10 years after sterilization vary depending on the type of procedure used, documented as low as 7.5 per 1000 procedures to as high as 36.5 per 1000 procedures. (See Tubal ligation methods below.)
Overall, all pregnancies, including ectopic pregnancies, are less common among patients who have had a female sterilization procedure than among patients who have not. However, if patients do have a pregnancy after tubal ligation, a greater percentage of these will be ectopic; approximately one third of pregnancies that occur after a tubal ligation will be ectopic pregnancies. The likelihood of ectopic pregnancy is higher among women sterilized before age 30 and differs depending on the type of sterilization procedure used. (See Tubal ligation methods below.)
Emotional After Effects
The majority of patients who undergo female sterilization procedures do not regret their decisions. However, regret appears to be more common among patients who undergo sterilization at a young age (often defined as younger than 30 years old), patients who are unmarried at the time of sterilization, patients who identify as a non-white race, patients with public insurance such as Medicaid, or patients who undergo sterilization immediately after or soon after the birth of a child. Regret has not been found to be associated with the number of children a person has at the time of sterilization.
Patients who have undergone female sterilization procedures have minimal or no changes in their menstrual patterns. They were more likely to have perceived improvements in their menstrual cycle, including decreases in the amount of bleeding, in the number of days of bleeding, and in menstrual pain.
Studies of hormone levels and ovarian reserve have demonstrated no significant changes after female sterilization, or inconsistent effects. There is no strong evidence that women undergoing sterilization will experience earlier onset of menopause.
Sexual function appears unchanged or improved after female sterilization compared with non-sterilized women.
Patients who had tubal occlusion surgeries have been found to be four to five times more likely to undergo hysterectomy later in life than those whose partners underwent vasectomy. There is no known biologic mechanism to support a causal relationship between tubal ligation and subsequent hysterectomy, but there is an association across all methods of tubal ligation.
Postablation tubal sterilization syndrome
Some women who have undergone tubal ligation prior to an endometrial ablation procedure experience cyclic or intermittent pelvic pain; this may happen in up to 10% of women who have undergone both surgeries.
Given its permanent nature, tubal ligation is contraindicated in patients who desire future pregnancy or who want to have the option of future pregnancy. In such cases, reversible methods of contraception are recommended.
Since most forms of tubal ligation require abdominal surgery under regional or general anesthesia, tubal ligation is also relatively contraindicated in patients for whom the risks of surgery and/or anesthesia are unacceptably high considering their other medical issues.
Tubal ligation through blocking or removing the tubes may be accomplished through an open abdominal surgery, a laparoscopic approach, or a hysteroscopic approach. Depending on the approach chosen, the patient will need to undergo local, general, or spinal (regional) anesthesia. The procedure may be performed either immediately after the end of a pregnancy, termed a "postpartum" or "postabortion tubal ligation", or more than six weeks after the end of a pregnancy, termed an "interval tubal ligation". The steps of the sterilization procedure will depend on the type of procedure being used. (See Tubal ligation methods below.)
If the patient chooses a postpartum tubal ligation, the procedure will further depend on the delivery method. If the patient delivers via Cesarean section, the surgeon will remove part or all of the fallopian tubes after the infant has been delivered and the uterus has been closed. Anesthesia for the tubal ligation will be the same as that being used for the Cesarean section itself, usually regional or general anesthesia. If the patient delivers vaginally and desires a postpartum tubal ligation, the surgeon will remove part or all of the fallopian tubes usually one or two days after the birth, during the same hospitalization.
If the patient chooses an interval tubal ligation, the procedure will typically be performed under general anesthesia in a hospital setting. Most tubal ligations are accomplished laparoscopically, with an incision at the umbilicus and zero, one, or two smaller incisions in the lower sides of the abdomen. It is also possible to perform the surgery without a laparoscope, using larger abdominal incisions. It is also possible to perform an interval tubal ligation hysteroscopically, which may be performed under local anesthesia, moderate sedation, or full general anesthesia. While no methods of hysteroscopic sterilization are currently on the market in the United States as of 2019, the Essure and Adiana systems were previously used for hysteroscopic sterilization, and research trials are investigating new hysteroscopic approaches.
Tubal ligation methods
There are a number of methods of removing or occluding the fallopian tubes, some of which rely on medical implants and devices.
Postpartum tubal ligation
Performed immediately after a delivery, this method removes a segment, or all, of both fallopian tubes. The most common techniques for partial bilateral salpingectomy are the Pomeroy or Parkland procedures. The ten year pregnancy rate is estimated at 7.5 pregnancies per 1000 procedures performed, and the ectopic pregnancy rate is estimated at 1.5 per 1000 procedures performed.
Interval tubal ligation
This method removes both tubes entirely, from the uterine cornuae out to the tubal fimbriae. This method has recently become more popular for female sterilization, given evidence to support the fallopian tube as the potential site of origin of some ovarian cancers. Some large medical systems such as Kaiser Permanente Northern California  have endorsed complete bilateral salpingectomy as the preferred means of female sterilization and professional medical societies such as the Society of Gynecologic Oncology  and the American College of Obstetricians and Gynecologists (ACOG) recommend discussing the benefits of salpingectomy during counseling for sterilization. While complete bilateral salpingectomy theoretically should have an efficacy rate that approaches 100 percent and eliminates the risk of tubal ectopic pregnancy, there is not high quality data available comparing this method to older methods.
This method uses electric current to cauterize sections of the fallopian tube, with or without subsequent division of the tube. The ten year pregnancy rate is estimated at 6.3 to 24.8 pregnancies per 1000 procedures performed, and the ectopic pregnancy rate is estimated at 17.1 per 1000 procedures performed.
This method uses electric current to cauterize the tube, but also allows radiating current to further damage the tubes as it spreads from the coagulation site. The tubes may also be transected after cauterization. The ten year pregnancy rate is estimated at 7.5 pregnancies per 1000 procedures performed.
This method uses a tubal clip (Filshie clip or Hulka clip) to permanently clip the fallopian tubes shut. Once applied and fastened, the clip blocks movement of eggs from the ovary to the uterus. The ten year pregnancy rate is estimated at 36.5 pregnancies per 1000 procedures performed, and the ectopic pregnancy rate is estimated at 8.5 per 1000 procedures performed.
Tubal ring (Fallope ring)
This method involves a doubling over of the fallopian tubes and application of a silastic band to the tube. The ten year pregnancy rate is estimated at 17.7 pregnancies per 1000 procedures performed, and the ectopic pregnancy rate is estimated at 8.5 per 1000 procedures performed.
Less commonly used or no longer used procedures
This method places two ligatures (sutures) around the Fallopian tube and removing the segment of tube between the ligatures. The medial ends of the Fallopian tubes on the side closer to the uterus are then connected to the back of the uterus itself.
Uchida tubal ligation
This method involves dissecting the Fallopian tube from the overlying connective tissue (serosa), placing two ligatures and excising a segment of the tube, then buries the end of the Fallopian tube closest to the uterus underneath the serosa. Dr. Uchida reported no failures among 20,000 procedures.
Essure tubal ligation
This method closed the fallopian tubes through a hysteroscopic approach by placing two small metal and fiber coils in the fallopian tubes through the fallopian ostia. After insertion, scar tissue forms around the coils, blocking off the fallopian tubes and preventing sperm from reaching the egg. It was removed from the US market in 2019.
Adiana tubal ligation
This method closed the fallopian tubes through a hysteroscopic approach by placing two small silicone pieces in the fallopian tubes. During the procedure, the health care provider heated a small portion of each fallopian tube and then inserts a tiny piece of silicone into each tube. After the procedure, scar tissue formed around the silicone inserts, blocking off the fallopian tubes and preventing sperm from reaching the egg. It is was removed from the US market in 2012.
Reversal or in vitro fertilization after tubal ligation
All tubal ligation procedures are considered permanent and are not reliably reversible forms of birth control. Patients who wish to have the option of future pregnancy should ideally be directed towards effective but reversal forms of birth control, rather than sterilization procedures. However, patients who desire pregnancy after having undergone a female sterilization procedure have two options.
Tubal reversal is a type of microsurgery to repair the fallopian tube after a tubal ligation procedure. Successful pregnancy rates after reversal surgery are 42-69%, depending on the sterilization technique that was used.
Alternatively, in vitro fertilization (IVF) may allow patients with absent or occluded fallopian tubes to successfully carry a pregnancy. The choice of whether to attempt tubal reversal or move straight to IVF depends on individual patient factors, including the likelihood of successful tubal reversal surgery and the age of the patient.
Recovery and rehabilitation
Most laparoscopic methods of interval tubal ligation are outpatient surgeries and do not require hospitalization overnight. Patients are counseled to expect some soreness but to expect to be ready to perform daily activities 1–2 days after surgery. Patients undergoing postpartum tubal ligations will not be delayed in their discharge from the hospital after birth, and recovery is not significantly different than normal postpartum recovery.
The first modern female sterilization procedure was performed in 1880 by Dr. Samuel Lungren of Toledo, Ohio, in the United States. Hysteroscopic tubal ligation was developed later by Mikulicz-Radecki and Freund.
Since its development, female sterilization has been periodically performed on patients without their informed consent, often specifically targeting marginalized populations. Given this history of human rights abuses, current sterilization policy in the United States requires a mandatory waiting period for tubal sterilization on Medicaid beneficiaries. This waiting period is not required for private insurance beneficiaries, which has the effect of selectively restricting low-income women's access to tubal sterilization.
Society and culture
Of the 64% of married or in-union women worldwide using some form of contraception, approximately one third (19% of all women) used female sterilization as their contraception, making it the most common contraceptive method globally. The percentage of women using female sterilization varies significantly between different regions of the world. Rates are highest in Asia, Latin America and the Caribbean, North America, Oceania, and selected countries in Western Europe, where rates of sterilization are often greater than 40%; rates in Africa, the Middle East, and parts of Eastern Europe, however, are significantly lower, sometimes less than 2%. An estimated 180 million women worldwide have undergone surgical sterilization, compared to approximately 42.5 million men who have undergone vasectomy.
In the United States, female sterilization is used by 30% of married couples and 22% of women who use any form of contraception, making it the second-most popular contraceptive after the birth control pill. Slightly more than 8.2 million women in the US use tubal ligation as their main form of contraception, and approximately 643,000 female sterilization procedures are performed each year in the United States.
- Trussell, James (2011). "Contraceptive efficacy". In Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 =
- Clarke-Pearson, Daniel L.; Geller, Elizabeth J. (March 2013). "Complications of Hysterectomy". Obstetrics & Gynecology. 121 (3): 654–673. doi:10.1097/AOG.0b013e3182841594. ISSN 0029-7844. PMID 23635631.
- Shuster, L. T; Gostout, B. S; Grossardt, B. R; Rocca, W. A (1 September 2008). "Prophylactic oophorectomy in premenopausal women and long-term health". Menopause International. 14 (3): 111–116. doi:10.1258/mi.2008.008016. ISSN 1754-0453. PMC 2585770. PMID 18714076.
- Committee On Practice Bulletins–Gynecology, Committee on Genetics (2017). "Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome". Obstetrics & Gynecology. 130 (3): e110–e126. doi:10.1097/AOG.0000000000002296. ISSN 0029-7844. PMID 28832484.
- "ACOG Practice Bulletin No. 208: Benefits and Risks of Sterilization". Obstetrics & Gynecology. 133 (3): e194–e207. March 2019. doi:10.1097/AOG.0000000000003111. ISSN 0029-7844. PMID 30640233.
- "U.S. Selected Practice Recommendations for Contraceptive Use, 2013". www.cdc.gov. Retrieved 9 July 2019.
- Gebel Berg, Erika (25 March 2015). "The Chemistry of the Pill". ACS Central Science. 1 (1): 5–7. doi:10.1021/acscentsci.5b00066. ISSN 2374-7943. PMC 4827491. PMID 27162937.
- Cibula, D.; Widschwendter, M.; Majek, O.; Dusek, L. (1 January 2011). "Tubal ligation and the risk of ovarian cancer: review and meta-analysis". Human Reproduction Update. 17 (1): 55–67. doi:10.1093/humupd/dmq030. ISSN 1355-4786. PMID 20634209.
- Lawrie, Theresa A; Kulier, Regina; Nardin, Juan Manuel (5 August 2016). Cochrane Fertility Regulation Group (ed.). "Techniques for the interruption of tubal patency for female sterilisation". Cochrane Database of Systematic Reviews (8): CD003034. doi:10.1002/14651858.CD003034.pub4. PMC 7004248. PMID 27494193.
- "ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy". Obstetrics & Gynecology. 131 (3): e91–e103. March 2018. doi:10.1097/AOG.0000000000002560. ISSN 0029-7844. PMID 29470343.
- Curtis, Kathryn M.; Mohllajee, Anshu P.; Peterson, Herbert B. (February 2006). "Regret following female sterilization at a young age: a systematic review". Contraception. 73 (2): 205–210. doi:10.1016/j.contraception.2005.08.006. PMID 16413851.
- Chi, I. C.; Jones, D. B. (October 1994). "Incidence, risk factors, and prevention of poststerilization regret in women: an updated international review from an epidemiological perspective". Obstetrical & Gynecological Survey. 49 (10): 722–732. doi:10.1097/00006254-199410000-00028. ISSN 0029-7828. PMID 7816397.
- Ercan, Cihangir Mutlu; Sakinci, Mehmet; Coksuer, Hakan Ko; Keskin, Ugur; Tapan, Serkan; Ergun, Ali (January 2013). "Ovarian reserve testing before and after laparoscopic tubal bipolar electrodesiccation and transection". European Journal of Obstetrics, Gynecology, and Reproductive Biology. 166 (1): 56–60. doi:10.1016/j.ejogrb.2012.09.013. ISSN 1872-7654. PMID 23036487.
- Costello, Caroline; Hillis, Susan D.; Marchbanks, Polly A.; Jamieson, Denise J.; Peterson, Herbert B.; US Collaborative Review of Sterilization Working Group (September 2002). "The effect of interval tubal sterilization on sexual interest and pleasure". Obstetrics and Gynecology. 100 (3): 511–517. doi:10.1016/s0029-7844(02)02042-2. ISSN 0029-7844. PMID 12220771.
- McCausland, Arthur M.; McCausland, Vance M. (June 2002). "Frequency of symptomatic cornual hematometra and postablation tubal sterilization syndrome after total rollerball endometrial ablation: a 10-year follow-up". American Journal of Obstetrics and Gynecology. 186 (6): 1274–1280, discussion 1280–1283. doi:10.1067/mob.2002.123730. ISSN 0002-9378. PMID 12066109.
- Bartz, Deborah; Greenberg, James A. (2008). "Sterilization in the United States". Reviews in Obstetrics & Gynecology. 1 (1): 23–32. ISSN 1941-2797. PMC 2492586. PMID 18701927.
- "Essure Permanent Birth Control". US Food and Drug Administration. 15 May 2019. Retrieved 31 July 2019.
- "Sterilization by the Pomeroy Operation". Atlasofpelvicsurgery.com. Retrieved 2013-06-25.
- "The Parkland Procedure". The Global Library of Women's Medicine. 24 July 2019.
- Powell, C. Bethan; Alabaster, Amy; Simmons, Sarah; Garcia, Christine; Martin, Maria; McBride-Allen, Sally; Littell, Ramey D. (November 2017). "Salpingectomy for Sterilization: Change in Practice in a Large Integrated Health Care System, 2011–2016". Obstetrics & Gynecology. 130 (5): 961–967. doi:10.1097/AOG.0000000000002312. ISSN 0029-7844. PMID 29016486.
- "Practice Resource: Salpingectomy for Ovarian Cancer Prevention" (PDF). May 2013. Retrieved 30 July 2019.
- "SGO Clinical Practice Statement: Salpingectomy for Ovarian Cancer Prevention". Society of Gynecologic Oncology. November 2013. Retrieved 30 July 2019.
- "ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention". Obstetrics and Gynecology. 133 (4): e279–e284. April 2019. doi:10.1097/AOG.0000000000003164. ISSN 1873-233X. PMID 30913199.
- "Sterilization by Electrocoagulation and Division via Laparoscopy". Atlasofpelvicsurgery.com. Retrieved 2013-06-25.
- "Hulka Clip Sterilization via Laparoscopy". Atlasofpelvicsurgery.com. Retrieved 2013-06-25.
- "Silastic Band Sterilization via Laparoscopy". Atlasofpelvicsurgery.com. Retrieved 2013-06-25.
- "Sterilization by the Modified Irving Technique". Atlasofpelvicsurgery.com. Retrieved 2013-06-25.
- Sciarra, John J. "Volume 6, Chapter 39. Surgical Procedures for Tubal Sterilization". www.glowm.com. Retrieved 31 August 2020.
- Green, L. R.; Laros, R. K. (June 1980). "Postpartum sterilization". Clinical Obstetrics and Gynecology. 23 (2): 647–659. doi:10.1097/00003081-198006000-00030. ISSN 0009-9201. PMID 6447003.
- Uchida, H. (1975-01-15). "Uchida tubal sterilization". American Journal of Obstetrics and Gynecology. 121 (2): 153–158. doi:10.1016/0002-9378(75)90630-4. ISSN 0002-9378. PMID 123119.
- "Essure™ System - P020014". Fda.gov. Retrieved 2013-06-25.
- "Conceptus(R) Announces Settlement of Patent Infringement Lawsuit With Hologic Nasdaq:CPTS". Globenewswire.com. 30 April 2012. Retrieved 25 June 2013.
- Committee on Ethics (April 2017). "Committee Opinion No. 695: Sterilization of Women". Obstetrics & Gynecology. 129 (4): e109–e116. doi:10.1097/AOG.0000000000002023. ISSN 0029-7844. PMID 28333823.
- van Seeters, Jacoba A.H.; Chua, Su Jen; Mol, Ben W.J.; Koks, Carolien A.M. (1 May 2017). "Tubal anastomosis after previous sterilization: a systematic review". Human Reproduction Update. 23 (3): 358–370. doi:10.1093/humupd/dmx003. ISSN 1355-4786. PMID 28333337.
- Boeckxstaens, A.; Devroey, P.; Collins, J.; Tournaye, H. (25 July 2007). "Getting pregnant after tubal sterilization: surgical reversal or IVF?". Human Reproduction. 22 (10): 2660–2664. doi:10.1093/humrep/dem248. ISSN 0268-1161. PMID 17670765.
- "Frequently Asked Questions: Special Procedures: Laparoscopy". American College of Obstetricians and Gynecologists. 1 February 2019. Retrieved 30 July 2019.
- "Frequently Asked Questions: Contraception: Postpartum Sterilization". American College of Obstetricians and Gynecologists. May 2016. Retrieved 30 July 2019.
- Siegler, A. M.; Grunebaum, A. (December 1980). "The 100th anniversary of tubal sterilization". Fertility and Sterility. 34 (6): 610–613. doi:10.1016/S0015-0282(16)45206-4. ISSN 0015-0282. PMID 7004916.
- "Eliminating forced, coercive and otherwise involuntary sterilization" (PDF). World Health Organization. 2014. Retrieved 30 July 2019.
- Moaddab, Amirhossein; McCullough, Laurence B.; Chervenak, Frank A.; Fox, Karin A.; Aagaard, Kjersti Marie; Salmanian, Bahram; Raine, Susan P.; Shamshirsaz, Alireza A. (1 June 2015). "Health care justice and its implications for current policy of a mandatory waiting period for elective tubal sterilization". American Journal of Obstetrics and Gynecology. 212 (6): 736–739. doi:10.1016/j.ajog.2015.03.049. ISSN 1097-6868. PMID 25935572.
- "Trends in Contraceptive Use Worldwide" (PDF). Department of Economic and Social Affairs, Population Division, United Nations. 2015. Retrieved July 8, 2019.
- EngenderHealth (Firm) (2002). Contraceptive sterilization : global issues and trends. Ross, John A., 1934-. New York, NY: EngenderHealth. ISBN 1885063318. OCLC 49322541.
- "Contraceptive Use in the United States". Guttmacher Institute. 4 August 2004. Retrieved 9 July 2019.
|Wikimedia Commons has media related to Tubal ligation.|